ONTOLOGY REPORT - ANNOTATIONS
| Term: | pharmaceutical |
|
| Accession: | CHEBI:52217
|
browse the term
|
| Definition: | Any substance introduced into a living organism with therapeutic or diagnostic purpose. |
| Synonyms: | related_synonym: | farmaco; medicament; pharmaceuticals |
| | alt_id: | CHEBI:33293; CHEBI:33294 |
|
|
1,2-dilauroyl-sn-glycero-3-phosphocholine
|
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
increases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
1-O-palmitoyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine
|
| G |
Lipg |
lipase, endothelial |
|
increases hydrolysis |
ISO |
18 |
71,795,150 |
71,816,056 |
RGD:6480464 |
CTD |
acetylsalicylic acid
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
decreases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
increases expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
affects expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
multiple interactions |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
EXP |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
increases expression |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Acap3 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 |
|
increases expression |
ISO |
5 |
172,749,741 |
172,764,436 |
RGD:6480464 |
CTD |
| G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
|
decreases expression |
ISO |
15 |
32,719,863 |
32,764,748 |
RGD:6480464 |
CTD |
| G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
|
increases expression |
ISO |
15 |
32,719,863 |
32,764,748 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
decreases expression |
ISO |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
decreases expression |
ISO |
11 |
25,434,262 |
25,443,144 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
affects binding |
EXP |
15 |
3,071,412 |
3,458,891 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects activity |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Aif1l |
allograft inflammatory factor 1-like |
|
increases expression |
ISO |
3 |
11,053,196 |
11,078,079 |
RGD:6480464 |
CTD |
| G |
Aimp2 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
|
decreases expression |
EXP |
12 |
11,028,968 |
11,038,458 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
decreases activity |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
decreases activity |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
decreases activity |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
increases expression |
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects binding |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
decreases expression |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Ano9 |
anoctamin 9 |
|
increases expression |
ISO |
1 |
201,298,523 |
201,323,708 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases activity |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
|
decreases expression |
ISO |
10 |
71,386,233 |
71,488,000 |
RGD:6480464 |
CTD |
| G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
increases response to substance |
ISO |
7 |
27,932,908 |
28,020,533 |
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoa1 |
apolipoprotein A-I |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
affects response to substance |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
decreases expression |
ISO |
19 |
52,854,657 |
52,856,625 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
increases expression |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
|
increases expression |
ISO |
8 |
79,824,737 |
79,846,702 |
RGD:6480464 |
CTD |
| G |
Asl |
argininosuccinate lyase |
|
decreases expression |
ISO |
12 |
27,702,882 |
27,720,230 |
RGD:6480464 |
CTD |
| G |
Astn2 |
astrotactin 2 |
|
increases expression |
ISO |
5 |
82,124,461 |
83,128,927 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
decreases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp5e |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp6v0b |
ATPase, H+ transporting, lysosomal V0 subunit B |
|
decreases expression |
ISO |
5 |
138,349,548 |
138,351,064 |
RGD:6480464 |
CTD |
| G |
Atp6v0d1 |
ATPase, H+ transporting, lysosomal V0 subunit D1 |
|
decreases expression |
ISO |
19 |
35,342,041 |
35,386,025 |
RGD:6480464 |
CTD |
| G |
Atraid |
all-trans retinoic acid-induced differentiation factor |
|
decreases expression |
ISO |
6 |
25,296,435 |
25,300,992 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
B4galt1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
increases expression |
ISO |
5 |
58,196,388 |
58,243,231 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
increases expression |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
decreases expression |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
|
decreases expression |
ISO |
12 |
22,586,411 |
22,644,378 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcar3 |
breast cancer anti-estrogen resistance 3 |
|
increases expression |
ISO |
2 |
219,075,206 |
219,188,344 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases cleavage |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
increases expression |
EXP |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Blmh |
bleomycin hydrolase |
|
decreases expression |
ISO |
10 |
67,195,276 |
67,238,359 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
increases expression |
ISO |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
increases expression |
ISO |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
decreases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brd4 |
bromodomain containing 4 |
|
increases expression |
ISO |
7 |
12,772,428 |
12,853,406 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
ISO |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Btg1 |
B-cell translocation gene 1, anti-proliferative |
|
increases expression |
EXP |
7 |
34,029,300 |
34,031,557 |
RGD:6480464 |
CTD |
| G |
Btn3a2 |
butyrophilin, subfamily 3, member A2 |
|
decreases expression |
ISO |
20 |
4,471,149 |
4,528,035 |
RGD:6480464 |
CTD |
| G |
Bzw1 |
basic leucine zipper and W2 domains 1 |
|
increases expression |
ISO |
9 |
57,053,423 |
57,065,699 |
RGD:6480464 |
CTD |
| G |
Cacng1 |
calcium channel, voltage-dependent, gamma subunit 1 |
|
decreases expression |
ISO |
10 |
97,105,707 |
97,118,400 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
increases expression |
ISO |
1 |
77,245,609 |
77,252,717 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
decreases expression |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
ISO |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
decreases expression |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Capsl |
calcyphosine-like |
|
increases expression |
ISO |
2 |
59,043,383 |
59,066,371 |
RGD:6480464 |
CTD |
| G |
Capza1 |
capping protein (actin filament) muscle Z-line, alpha 1 |
|
increases expression |
ISO |
2 |
200,080,802 |
200,125,881 |
RGD:6480464 |
CTD |
| G |
Capza2 |
capping protein (actin filament) muscle Z-line, alpha 2 |
|
increases expression |
ISO |
4 |
43,293,339 |
43,329,229 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
multiple interactions |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
decreases expression |
EXP |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Ccdc176 |
coiled-coil domain containing 176 |
|
increases expression |
ISO |
6 |
108,473,030 |
108,498,836 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
increases expression |
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
affects expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnj |
cyclin J |
|
increases expression |
ISO |
1 |
245,997,221 |
246,015,024 |
RGD:6480464 |
CTD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
affects response to substance |
ISO |
8 |
128,759,943 |
128,769,341 |
RGD:6480464 |
CTD |
| G |
Ccr3 |
chemokine (C-C motif) receptor 3 |
|
increases expression |
ISO |
8 |
128,759,943 |
128,769,341 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
decreases expression |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd274 |
CD274 molecule |
|
increases expression |
ISO |
1 |
233,053,607 |
233,065,384 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
decreases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
decreases expression |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
multiple interactions |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
decreases expression |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
affects expression |
EXP |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cd6 |
Cd6 molecule |
|
decreases expression |
ISO |
1 |
213,290,835 |
213,329,594 |
RGD:6480464 |
CTD |
| G |
Cd74 |
Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
decreases expression |
ISO |
18 |
56,756,511 |
56,765,711 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8a molecule |
|
decreases expression |
ISO |
4 |
104,589,922 |
104,594,159 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
decreases expression |
ISO |
8 |
20,164,150 |
20,176,763 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
decreases expression |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdk19 |
cyclin-dependent kinase 19 |
|
increases expression |
ISO |
20 |
44,527,463 |
44,670,028 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases activity |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
affects expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cds1 |
CDP-diacylglycerol synthase 1 |
|
increases expression |
EXP |
14 |
9,074,826 |
9,135,391 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
affects hydrolysis |
ISO |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases hydrolysis |
ISO |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
|
increases expression |
ISO |
1 |
128,609,727 |
128,720,325 |
RGD:6480464 |
CTD |
| G |
Chmp1a |
charged multivesicular body protein 1A |
|
decreases expression |
ISO |
19 |
53,521,981 |
53,530,261 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
decreases phosphorylation |
EXP |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
|
increases expression |
ISO |
2 |
181,611,639 |
181,616,222 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
increases expression |
EXP |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clip3 |
CAP-GLY domain containing linker protein 3 |
|
increases expression |
ISO |
1 |
85,238,779 |
85,253,538 |
RGD:6480464 |
CTD |
| G |
Clk2 |
CDC-like kinase 2 |
|
decreases expression |
ISO |
2 |
181,244,665 |
181,257,364 |
RGD:6480464 |
CTD |
| G |
Clk3 |
CDC-like kinase 3 |
|
decreases expression |
ISO |
8 |
61,519,196 |
61,532,816 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
decreases expression |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
increases expression |
ISO |
10 |
11,598,680 |
11,724,122 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
decreases expression |
ISO |
5 |
145,374,596 |
145,394,045 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
increases expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
decreases expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Csta |
cystatin A (stefin A) |
|
increases expression |
ISO |
11 |
66,456,248 |
66,467,253 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
multiple interactions |
EXP |
1 |
21,327,099 |
21,330,215 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases localization |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases phosphorylation |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases phosphorylation |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases localization |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases ubiquitination |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
EXP |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyc1 |
cytochrome c-1 |
|
increases expression |
EXP |
7 |
114,394,178 |
114,396,563 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects response to substance |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
increases expression |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
affects response to substance |
ISO |
X |
94,802,078 |
94,803,097 |
RGD:6480464 |
CTD |
| G |
Cysltr2 |
cysteinyl leukotriene receptor 2 |
|
affects response to substance |
ISO |
15 |
53,647,500 |
53,648,429 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
decreases expression |
ISO |
2 |
83,281,937 |
83,335,284 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddx18 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 18 |
|
decreases expression |
ISO |
13 |
33,587,928 |
33,601,436 |
RGD:6480464 |
CTD |
| G |
Ddx5 |
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
increases expression |
ISO |
10 |
96,131,888 |
96,139,423 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
increases expression |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dennd5a |
DENN/MADD domain containing 5A |
|
increases expression |
ISO |
1 |
167,519,644 |
167,586,964 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
decreases expression |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
decreases expression |
ISO |
6 |
109,156,751 |
109,180,537 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
affects expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
affects expression |
EXP |
1 |
259,754,234 |
259,767,645 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
increases expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
multiple interactions |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
ISO |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Efcab4a |
EF-hand calcium binding domain 4A |
|
increases expression |
ISO |
1 |
201,647,804 |
201,653,175 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
decreases expression |
ISO |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
increases expression |
ISO |
20 |
4,021,679 |
4,033,709 |
RGD:6480464 |
CTD |
| G |
Eif2s2 |
eukaryotic translation initiation factor 2, subunit 2 beta |
|
increases expression |
ISO |
3 |
145,346,392 |
145,367,117 |
RGD:6480464 |
CTD |
| G |
Elf4 |
E74-like factor 4 (ets domain transcription factor) |
|
decreases expression |
ISO |
X |
134,808,886 |
134,818,835 |
RGD:6480464 |
CTD |
| G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
increases expression |
ISO |
8 |
82,922,551 |
82,948,348 |
RGD:6480464 |
CTD |
| G |
Elovl5 |
ELOVL fatty acid elongase 5 |
|
decreases expression |
ISO |
8 |
82,922,551 |
82,948,348 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
decreases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
increases expression |
EXP |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
increases expression |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
decreases expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
affects cleavage |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
ISO |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
decreases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
affects expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fat3 |
FAT tumor suppressor homolog 3 (Drosophila) |
|
increases expression |
ISO |
8 |
12,701,734 |
13,283,589 |
RGD:6480464 |
CTD |
| G |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
|
increases expression |
ISO |
15 |
87,093,141 |
87,113,003 |
RGD:6480464 |
CTD |
| G |
Fbxo11 |
F-box protein 11 |
|
increases expression |
ISO |
6 |
11,542,561 |
11,566,829 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
|
affects response to substance |
ISO |
13 |
89,429,982 |
89,436,507 |
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
affects response to substance |
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:6480464 |
CTD |
| G |
Fcer1g |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
|
decreases expression |
ISO |
13 |
87,119,464 |
87,123,902 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
increases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
decreases expression |
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Flii |
flightless I homolog (Drosophila) |
|
decreases expression |
ISO |
10 |
46,860,271 |
46,874,196 |
RGD:6480464 |
CTD |
| G |
Flot2 |
flotillin 2 |
|
decreases expression |
ISO |
10 |
64,081,463 |
64,104,166 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosb |
FBJ osteosarcoma oncogene B |
|
decreases expression |
ISO |
1 |
78,668,497 |
78,673,330 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fpr1 |
formyl peptide receptor 1 |
|
decreases expression |
ISO |
1 |
56,587,183 |
56,588,390 |
RGD:6480464 |
CTD |
| G |
Fpr3 |
formyl peptide receptor 3 |
|
increases expression |
ISO |
1 |
56,730,912 |
56,783,230 |
RGD:6480464 |
CTD |
| G |
Fpr3 |
formyl peptide receptor 3 |
|
multiple interactions |
ISO |
1 |
56,730,912 |
56,783,230 |
RGD:6480464 |
CTD |
| G |
Fsip1 |
fibrous sheath interacting protein 1 |
|
affects response to substance |
ISO |
3 |
104,629,182 |
104,680,197 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
affects expression |
EXP |
2 |
46,542,246 |
46,550,678 |
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
decreases expression |
ISO |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Fxr2 |
fragile X mental retardation, autosomal homolog 2 |
|
decreases expression |
ISO |
10 |
56,450,356 |
56,470,419 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
increases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pc3 |
glucose 6 phosphatase, catalytic, 3 |
|
increases expression |
ISO |
10 |
91,260,522 |
91,264,754 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
decreases response to substance |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
decreases activity |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gabarap |
GABA(A) receptor-associated protein |
|
decreases expression |
ISO |
10 |
56,837,772 |
56,840,707 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
affects response to substance |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
multiple interactions |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfra3 |
GDNF family receptor alpha 3 |
|
increases expression |
ISO |
18 |
27,167,576 |
27,195,848 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
increases expression |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gkn1 |
gastrokine 1 |
|
affects expression |
ISO |
4 |
121,496,151 |
121,501,439 |
RGD:6480464 |
CTD |
| G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
decreases expression |
ISO |
12 |
19,597,312 |
19,602,329 |
RGD:6480464 |
CTD |
| G |
Gp1ba |
glycoprotein Ib (platelet), alpha polypeptide |
|
decreases response to substance |
ISO |
10 |
57,519,338 |
57,522,204 |
RGD:6480464 |
CTD |
| G |
Gp1ba |
glycoprotein Ib (platelet), alpha polypeptide |
|
affects response to substance |
ISO |
10 |
57,519,338 |
57,522,204 |
RGD:6480464 |
CTD |
| G |
Gp1ba |
glycoprotein Ib (platelet), alpha polypeptide |
|
increases response to substance |
ISO |
10 |
57,519,338 |
57,522,204 |
RGD:6480464 |
CTD |
| G |
Gp6 |
glycoprotein 6 (platelet) |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases activity |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
affects binding |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
EXP |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gtf2i |
general transcription factor II I |
|
decreases expression |
ISO |
12 |
23,470,042 |
23,545,621 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
decreases expression |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Guk1 |
guanylate kinase 1 |
|
decreases expression |
ISO |
10 |
45,489,304 |
45,497,364 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
decreases expression |
ISO |
2 |
44,488,295 |
44,500,128 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
EXP |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
increases expression |
EXP |
18 |
29,143,567 |
29,153,944 |
RGD:6480464 |
CTD |
| G |
Hbg1 |
hemoglobin, gamma A |
|
increases expression |
ISO |
1 |
161,640,359 |
161,641,737 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
decreases expression |
ISO |
3 |
143,447,697 |
143,490,281 |
RGD:6480464 |
CTD |
| G |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
|
decreases expression |
ISO |
11 |
65,619,701 |
65,643,533 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
multiple interactions |
ISO |
18 |
30,857,209 |
30,875,986 |
RGD:6480464 |
CTD |
| G |
Hdac4 |
histone deacetylase 4 |
|
increases expression |
ISO |
9 |
91,147,435 |
91,389,810 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
decreases expression |
ISO |
2 |
179,981,346 |
179,991,892 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hlcs |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
increases expression |
ISO |
11 |
34,382,010 |
34,539,032 |
RGD:6480464 |
CTD |
| G |
Hmmr |
hyaluronan mediated motility receptor (RHAMM) |
|
increases expression |
ISO |
10 |
25,733,375 |
25,762,825 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
decreases expression |
EXP |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hnmt |
histamine N-methyltransferase |
|
affects response to substance |
ISO |
3 |
2,057,938 |
2,089,955 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
decreases expression |
EXP |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
|
decreases expression |
EXP |
15 |
27,516,839 |
27,546,646 |
RGD:6480464 |
CTD |
| G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
|
increases expression |
ISO |
13 |
93,978,865 |
93,987,654 |
RGD:6480464 |
CTD |
| G |
Hnrnpul1 |
heterogeneous nuclear ribonucleoprotein U-like 1 |
|
decreases expression |
ISO |
1 |
80,926,575 |
80,960,767 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
decreases expression |
ISO |
14 |
10,861,054 |
10,864,322 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases activity |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
decreases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Iars |
isoleucyl-tRNA synthetase |
|
decreases expression |
ISO |
17 |
20,895,852 |
20,942,180 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
decreases expression |
EXP |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
affects expression |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
affects response to substance |
ISO |
16 |
71,866,340 |
71,878,373 |
RGD:6480464 |
CTD |
| G |
Ifi30 |
interferon gamma inducible protein 30 |
|
decreases expression |
ISO |
16 |
19,181,236 |
19,185,438 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ift27 |
intraflagellar transport 27 homolog (Chlamydomonas) |
|
increases expression |
ISO |
7 |
116,080,404 |
116,096,150 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
decreases expression |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
increases expression |
ISO |
1 |
42,253,273 |
42,341,646 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases activity |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases expression |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases phosphorylation |
EXP |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases response to substance |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
affects response to substance |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
increases expression |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
EXP |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
multiple interactions |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
affects response to substance |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il17a |
interleukin 17A |
|
affects response to substance |
ISO |
9 |
19,454,979 |
19,458,467 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
affects response to substance |
ISO |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects response to substance |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
multiple interactions |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Il2rg |
interleukin 2 receptor, gamma |
|
decreases expression |
ISO |
X |
89,342,055 |
89,345,715 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
decreases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
increases expression |
ISO |
2 |
59,103,992 |
59,128,004 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin-linked kinase |
|
decreases activity |
ISO |
1 |
163,481,299 |
163,487,550 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin-linked kinase |
|
decreases expression |
ISO |
1 |
163,481,299 |
163,487,550 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
EXP |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf9 |
interferon regulatory factor 9 |
|
decreases expression |
ISO |
15 |
33,739,755 |
33,744,958 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
affects response to substance |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin, alpha 2 |
|
multiple interactions |
ISO |
2 |
46,967,681 |
47,080,909 |
RGD:6480464 |
CTD |
| G |
Itga2b |
integrin, alpha 2B |
|
decreases expression |
ISO |
10 |
91,557,086 |
91,574,194 |
RGD:6480464 |
CTD |
| G |
Itga2b |
integrin, alpha 2B |
|
multiple interactions |
ISO |
10 |
91,557,086 |
91,574,194 |
RGD:6480464 |
CTD |
| G |
Itga2b |
integrin, alpha 2B |
|
multiple interactions |
ISO |
10 |
91,557,086 |
91,574,194 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
decreases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
multiple interactions |
ISO |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Junb |
jun B proto-oncogene |
|
increases expression |
EXP |
19 |
24,831,536 |
24,833,320 |
RGD:6480464 |
CTD |
| G |
Jund |
jun D proto-oncogene |
|
decreases expression |
ISO |
16 |
19,239,694 |
19,241,529 |
RGD:6480464 |
CTD |
| G |
Kat7 |
K (lysine) acetyltransferase 7 |
|
decreases expression |
ISO |
10 |
83,960,245 |
83,995,124 |
RGD:6480464 |
CTD |
| G |
Kcnmb4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
|
decreases expression |
ISO |
7 |
55,751,633 |
55,807,075 |
RGD:6480464 |
CTD |
| G |
Kctd13 |
potassium channel tetramerisation domain containing 13 |
|
increases expression |
EXP |
1 |
186,104,306 |
186,122,853 |
RGD:6480464 |
CTD |
| G |
Kdm5b |
lysine (K)-specific demethylase 5B |
|
decreases expression |
ISO |
13 |
47,502,602 |
47,576,946 |
RGD:6480464 |
CTD |
| G |
Kif20b |
kinesin family member 20B |
|
decreases expression |
ISO |
1 |
238,892,139 |
238,947,678 |
RGD:6480464 |
CTD |
| G |
Kif21a |
kinesin family member 21A |
|
increases expression |
ISO |
7 |
129,337,712 |
129,456,728 |
RGD:6480464 |
CTD |
| G |
Klrb1 |
killer cell lectin-like receptor subfamily B, member 1 |
|
increases expression |
ISO |
4 |
166,253,201 |
166,271,896 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
decreases activity |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kpna3 |
karyopherin alpha 3 |
|
increases expression |
ISO |
15 |
40,513,214 |
40,585,152 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
decreases expression |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
multiple interactions |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
decreases activity |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases activity |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases activity |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Lct |
lactase |
|
increases activity |
EXP |
13 |
40,990,315 |
41,043,388 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
multiple interactions |
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
EXP |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lmo7 |
LIM domain 7 |
|
increases expression |
ISO |
15 |
85,710,975 |
85,928,469 |
RGD:6480464 |
CTD |
| G |
LOC100360882 |
Mps one binder kinase activator-like 2 |
|
increases expression |
ISO |
1 |
202,138,589 |
202,195,526 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
decreases expression |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
Lsmd1 |
LSM domain containing 1 |
|
increases expression |
ISO |
10 |
56,190,119 |
56,191,724 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
affects response to substance |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
affects response to substance |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
affects response to substance |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
affects response to substance |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Ltc4s |
leukotriene C4 synthase |
|
affects response to substance |
ISO |
10 |
35,786,877 |
35,788,838 |
RGD:6480464 |
CTD |
| G |
Ly9 |
lymphocyte antigen 9 |
|
increases expression |
ISO |
13 |
87,581,203 |
87,600,810 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Madd |
MAP-kinase activating death domain |
|
decreases expression |
ISO |
3 |
75,498,321 |
75,541,073 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
decreases expression |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
decreases expression |
ISO |
8 |
67,313,472 |
67,542,723 |
RGD:6480464 |
CTD |
| G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
|
decreases expression |
ISO |
9 |
39,087,924 |
39,213,053 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
|
decreases expression |
ISO |
8 |
112,497,626 |
112,531,778 |
RGD:6480464 |
CTD |
| G |
Mcam |
melanoma cell adhesion molecule |
|
increases expression |
ISO |
8 |
47,105,632 |
47,127,936 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
EXP |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
decreases expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Med4 |
mediator complex subunit 4 |
|
increases expression |
ISO |
15 |
54,158,386 |
54,168,660 |
RGD:6480464 |
CTD |
| G |
Mlf2 |
myeloid leukemia factor 2 |
|
decreases expression |
ISO |
4 |
161,058,932 |
161,063,117 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
increases expression |
EXP |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
decreases expression |
EXP |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mob2 |
MOB kinase activator 2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
EXP |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mpzl1 |
myelin protein zero-like 1 |
|
increases expression |
EXP |
13 |
81,321,155 |
81,357,929 |
RGD:6480464 |
CTD |
| G |
Mrpl46 |
mitochondrial ribosomal protein L46 |
|
increases expression |
ISO |
1 |
134,498,789 |
134,507,602 |
RGD:6480464 |
CTD |
| G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
increases expression |
EXP |
MT |
5,323 |
6,867 |
RGD:6480464 |
CTD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
increases expression |
EXP |
MT |
2,740 |
3,694 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mta1 |
metastasis associated 1 |
|
increases expression |
ISO |
6 |
138,118,468 |
138,143,983 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Naa15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
|
decreases expression |
EXP |
2 |
140,308,955 |
140,371,869 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
decreases activity |
EXP |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Ndst2 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
|
increases expression |
ISO |
15 |
3,788,239 |
3,798,682 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases localization |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases degradation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases degradation |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
ISO |
1 |
83,865,440 |
83,873,010 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
ISO |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Ngfr |
nerve growth factor receptor |
|
increases expression |
ISO |
10 |
84,262,804 |
84,281,006 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
decreases expression |
ISO |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nkg7 |
natural killer cell group 7 sequence |
|
decreases expression |
ISO |
1 |
93,813,123 |
93,814,190 |
RGD:6480464 |
CTD |
| G |
Nkx2-1 |
NK2 homeobox 1 |
|
affects expression |
EXP |
6 |
76,916,943 |
76,920,133 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
increases expression |
ISO |
8 |
114,205,773 |
114,212,486 |
RGD:6480464 |
CTD |
| G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
|
decreases expression |
EXP |
1 |
251,297,417 |
251,308,127 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Npepps |
aminopeptidase puromycin sensitive |
|
decreases expression |
ISO |
10 |
85,927,819 |
86,011,826 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
multiple interactions |
ISO |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
affects expression |
EXP |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide B |
|
increases expression |
EXP |
5 |
165,062,348 |
165,063,650 |
RGD:6480464 |
CTD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
decreases expression |
ISO |
2 |
182,724,916 |
182,740,242 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
increases expression |
ISO |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nrcam |
neuronal cell adhesion molecule |
|
decreases expression |
ISO |
6 |
63,717,460 |
64,015,522 |
RGD:6480464 |
CTD |
| G |
Nubp2 |
nucleotide binding protein 2 |
|
decreases expression |
ISO |
10 |
14,131,309 |
14,134,994 |
RGD:6480464 |
CTD |
| G |
Nubp2 |
nucleotide binding protein 2 |
|
decreases expression |
ISO |
10 |
14,131,309 |
14,134,994 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Orc4 |
origin recognition complex, subunit 4 |
|
increases expression |
ISO |
3 |
29,813,264 |
29,851,852 |
RGD:6480464 |
CTD |
| G |
Osr1 |
odd-skipped related 1 (Drosophila) |
|
increases expression |
ISO |
6 |
33,074,410 |
33,076,769 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
decreases expression |
ISO |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
decreases response to substance |
ISO |
2 |
150,460,361 |
150,465,855 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcdh17 |
protocadherin 17 |
|
increases expression |
ISO |
15 |
66,391,901 |
66,482,530 |
RGD:6480464 |
CTD |
| G |
Pcnp |
PEST proteolytic signal containing nuclear protein |
|
increases expression |
ISO |
11 |
45,572,442 |
45,580,616 |
RGD:6480464 |
CTD |
| G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
decreases expression |
ISO |
2 |
1,923,309 |
1,970,238 |
RGD:6480464 |
CTD |
| G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
|
decreases expression |
ISO |
8 |
48,879,382 |
48,901,968 |
RGD:6480464 |
CTD |
| G |
Pdcd10 |
programmed cell death 10 |
|
increases expression |
ISO |
2 |
166,402,652 |
166,445,015 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
decreases expression |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
decreases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
decreases expression |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pef1 |
penta-EF hand domain containing 1 |
|
decreases expression |
ISO |
5 |
149,135,320 |
149,158,586 |
RGD:6480464 |
CTD |
| G |
Pepd |
peptidase D |
|
increases activity |
ISO |
1 |
87,421,576 |
87,547,908 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
decreases expression |
ISO |
17 |
78,241,182 |
78,268,272 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
decreases expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb2 |
prohibitin 2 |
|
decreases expression |
ISO |
4 |
160,835,328 |
160,839,933 |
RGD:6480464 |
CTD |
| G |
Pi4kb |
phosphatidylinositol 4-kinase, catalytic, beta |
|
decreases expression |
ISO |
2 |
189,874,613 |
189,906,640 |
RGD:6480464 |
CTD |
| G |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
|
decreases expression |
ISO |
1 |
146,754,085 |
146,834,197 |
RGD:6480464 |
CTD |
| G |
Pik3c2a |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
|
decreases expression |
ISO |
1 |
174,430,831 |
174,537,706 |
RGD:6480464 |
CTD |
| G |
Pitx1 |
paired-like homeodomain 1 |
|
increases expression |
ISO |
17 |
14,834,144 |
14,840,303 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
decreases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
increases expression |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
multiple interactions |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
increases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
affects expression |
EXP |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcd4 |
phospholipase C, delta 4 |
|
increases expression |
EXP |
9 |
73,878,506 |
73,905,127 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
increases expression |
EXP |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases response to substance |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
|
increases expression |
ISO |
10 |
56,552,872 |
56,579,172 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
decreases expression |
ISO |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
affects activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases activity |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
decreases activity |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
decreases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
ISO |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
increases expression |
EXP |
20 |
6,479,108 |
6,544,255 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases activity |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppib |
peptidylprolyl isomerase B |
|
decreases expression |
ISO |
8 |
70,343,463 |
70,349,320 |
RGD:6480464 |
CTD |
| G |
Ppig |
peptidylprolyl isomerase G |
|
increases expression |
ISO |
3 |
51,866,989 |
51,895,893 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
decreases expression |
ISO |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
EXP |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp4c |
protein phosphatase 4, catalytic subunit |
|
decreases expression |
ISO |
1 |
185,961,286 |
185,967,851 |
RGD:6480464 |
CTD |
| G |
Prep |
prolyl endopeptidase |
|
decreases expression |
ISO |
20 |
49,024,917 |
49,144,670 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases cleavage |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases expression |
EXP |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
decreases expression |
EXP |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psd |
pleckstrin and Sec7 domain containing |
|
increases expression |
ISO |
1 |
251,527,890 |
251,542,740 |
RGD:6480464 |
CTD |
| G |
Psmc6 |
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
decreases expression |
ISO |
15 |
21,217,367 |
21,239,320 |
RGD:6480464 |
CTD |
| G |
Psmd12 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
increases expression |
ISO |
10 |
96,881,373 |
96,907,258 |
RGD:6480464 |
CTD |
| G |
Ptgdr2 |
prostaglandin D2 receptor 2 |
|
affects response to substance |
ISO |
1 |
213,437,202 |
213,438,498 |
RGD:6480464 |
CTD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
affects response to substance |
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases acetylation |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases response to substance |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases response to substance |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases degradation |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
affects response to substance |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases activity |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
ISO |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptprcap |
protein tyrosine phosphatase, receptor type, C-associated protein |
|
decreases expression |
ISO |
1 |
206,738,735 |
206,740,894 |
RGD:6480464 |
CTD |
| G |
Pum2 |
pumilio homolog 2 (Drosophila) |
|
increases expression |
ISO |
6 |
32,153,090 |
32,233,940 |
RGD:6480464 |
CTD |
| G |
Pura |
purine rich element binding protein A |
|
increases expression |
EXP |
18 |
28,916,722 |
28,925,008 |
RGD:6480464 |
CTD |
| G |
Pus1 |
pseudouridylate synthase 1 |
|
increases expression |
ISO |
12 |
46,024,978 |
46,033,733 |
RGD:6480464 |
CTD |
| G |
Pxn |
paxillin |
|
decreases expression |
ISO |
12 |
42,322,193 |
42,370,507 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
affects binding |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Rab2a |
RAB2A, member RAS oncogene family |
|
increases expression |
ISO |
5 |
22,389,585 |
22,452,198 |
RGD:6480464 |
CTD |
| G |
Rabggta |
Rab geranylgeranyltransferase, alpha subunit |
|
increases expression |
ISO |
15 |
33,862,275 |
33,868,619 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases expression |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Ralb |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
|
decreases expression |
ISO |
13 |
32,229,646 |
32,238,410 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Reep6 |
receptor accessory protein 6 |
|
increases expression |
ISO |
7 |
10,885,266 |
10,891,936 |
RGD:6480464 |
CTD |
| G |
Reg1a |
regenerating islet-derived 1 alpha |
|
decreases response to substance |
EXP |
4 |
112,386,071 |
112,389,205 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases localization |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
decreases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
RGD1303003 |
homolog of zebrafish ES1 |
|
increases expression |
ISO |
20 |
10,851,555 |
10,859,652 |
RGD:6480464 |
CTD |
| G |
RGD1561113 |
similar to Hypothetical UPF0184 protein C9orf16 homolog |
|
increases expression |
ISO |
3 |
11,505,289 |
11,508,067 |
RGD:6480464 |
CTD |
| G |
Rgs7bp |
regulator of G-protein signaling 7 binding protein |
|
affects response to substance |
ISO |
2 |
35,993,050 |
36,085,686 |
RGD:6480464 |
CTD |
| G |
Rhog |
ras homolog family member G |
|
decreases expression |
ISO |
1 |
159,724,016 |
159,735,532 |
RGD:6480464 |
CTD |
| G |
Rnase1 |
ribonuclease, RNase A family, 1 (pancreatic) |
|
increases expression |
ISO |
15 |
27,123,440 |
27,124,991 |
RGD:6480464 |
CTD |
| G |
Rnase6 |
ribonuclease, RNase A family, 6 |
|
increases expression |
ISO |
15 |
27,117,646 |
27,118,107 |
RGD:6480464 |
CTD |
| G |
Rnd2 |
Rho family GTPase 2 |
|
increases expression |
ISO |
10 |
90,493,477 |
90,497,048 |
RGD:6480464 |
CTD |
| G |
Rnf26 |
ring finger protein 26 |
|
increases expression |
ISO |
8 |
47,092,910 |
47,095,108 |
RGD:6480464 |
CTD |
| G |
Rpl34 |
ribosomal protein L34 |
|
increases expression |
ISO |
2 |
228,146,286 |
228,150,017 |
RGD:6480464 |
CTD |
| G |
Rpn1 |
ribophorin I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps16 |
ribosomal protein S16 |
|
increases expression |
ISO |
1 |
83,444,204 |
83,463,592 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps27a |
ribosomal protein S27a |
|
increases expression |
ISO |
14 |
110,559,621 |
110,561,451 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
affects response to substance |
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
|
decreases expression |
ISO |
20 |
1,412,553 |
1,416,692 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
increases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
S100a4 |
S100 calcium-binding protein A4 |
|
decreases expression |
ISO |
2 |
182,885,070 |
182,887,380 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
multiple interactions |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
increases expression |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Sbsn |
suprabasin |
|
multiple interactions |
ISO |
1 |
85,796,224 |
85,800,672 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
affects expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
multiple interactions |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
decreases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
affects expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases expression |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Scfd2 |
sec1 family domain containing 2 |
|
increases expression |
ISO |
14 |
36,058,698 |
36,386,253 |
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
increases expression |
ISO |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Sdc4 |
syndecan 4 |
|
decreases expression |
ISO |
3 |
155,446,138 |
155,464,825 |
RGD:6480464 |
CTD |
| G |
Sds |
serine dehydratase |
|
increases expression |
ISO |
12 |
37,281,091 |
37,288,403 |
RGD:6480464 |
CTD |
| G |
Sec13 |
SEC13 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
4 |
149,637,058 |
149,650,449 |
RGD:6480464 |
CTD |
| G |
Sell |
selectin L |
|
decreases expression |
ISO |
13 |
79,827,342 |
79,845,296 |
RGD:6480464 |
CTD |
| G |
Selm |
selenoprotein M |
|
increases expression |
ISO |
14 |
84,157,831 |
84,160,413 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
decreases expression |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
increases expression |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
multiple interactions |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
decreases expression |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
increases expression |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
decreases expression |
ISO |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
decreases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
increases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
EXP |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sftpd |
surfactant protein D |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
increases activity |
ISO |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Si |
sucrase-isomaltase (alpha-glucosidase) |
|
decreases activity |
EXP |
2 |
163,520,975 |
163,601,280 |
RGD:6480464 |
CTD |
| G |
Siah2 |
siah E3 ubiquitin protein ligase 2 |
|
decreases expression |
ISO |
2 |
148,022,641 |
148,040,390 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
decreases expression |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
affects response to substance |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
decreases activity |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases activity |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases expression |
ISO |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc25a5 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
|
increases expression |
EXP |
X |
8,072,239 |
8,075,306 |
RGD:6480464 |
CTD |
| G |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
|
affects response to substance |
ISO |
4 |
157,781,178 |
157,800,038 |
RGD:6480464 |
CTD |
| G |
Smap2 |
small ArfGAP2 |
|
affects response to substance |
ISO |
5 |
141,544,552 |
141,590,955 |
RGD:6480464 |
CTD |
| G |
Smc4 |
structural maintenance of chromosomes 4 |
|
decreases expression |
ISO |
2 |
158,987,318 |
159,015,705 |
RGD:6480464 |
CTD |
| G |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
10 |
96,170,590 |
96,269,365 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
multiple interactions |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spag6 |
sperm associated antigen 6 |
|
increases expression |
ISO |
11 |
86,208,991 |
86,321,358 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
multiple interactions |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
decreases expression |
ISO |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
|
decreases expression |
ISO |
3 |
8,956,380 |
9,021,831 |
RGD:6480464 |
CTD |
| G |
Srpx |
sushi-repeat-containing protein, X-linked |
|
decreases expression |
ISO |
X |
24,833,279 |
24,904,349 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
increases expression |
ISO |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
Stambp |
Stam binding protein |
|
increases expression |
ISO |
4 |
117,766,905 |
117,791,399 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
decreases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
decreases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
decreases phosphorylation |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
decreases expression |
ISO |
10 |
89,716,624 |
89,743,134 |
RGD:6480464 |
CTD |
| G |
Stat6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
|
multiple interactions |
ISO |
7 |
67,623,534 |
67,642,283 |
RGD:6480464 |
CTD |
| G |
Stk10 |
serine/threonine kinase 10 |
|
affects response to substance |
ISO |
10 |
17,379,245 |
17,481,768 |
RGD:6480464 |
CTD |
| G |
Strn4 |
striatin, calmodulin binding protein 4 |
|
increases expression |
ISO |
1 |
77,140,308 |
77,166,074 |
RGD:6480464 |
CTD |
| G |
Stxbp1 |
syntaxin binding protein 1 |
|
affects expression |
EXP |
3 |
11,762,105 |
11,825,531 |
RGD:6480464 |
CTD |
| G |
Sumo1 |
SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) |
|
decreases expression |
ISO |
9 |
58,212,538 |
58,242,760 |
RGD:6480464 |
CTD |
| G |
Sumo3 |
SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) |
|
increases expression |
ISO |
20 |
11,393,957 |
11,404,510 |
RGD:6480464 |
CTD |
| G |
Sun2 |
Sad1 and UNC84 domain containing 2 |
|
increases expression |
ISO |
7 |
117,962,517 |
117,978,876 |
RGD:6480464 |
CTD |
| G |
Tacc3 |
transforming, acidic coiled-coil containing protein 3 |
|
decreases expression |
ISO |
14 |
82,746,460 |
82,760,864 |
RGD:6480464 |
CTD |
| G |
Taf6 |
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
12 |
17,620,900 |
17,629,268 |
RGD:6480464 |
CTD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
affects response to substance |
ISO |
20 |
4,770,446 |
4,784,488 |
RGD:6480464 |
CTD |
| G |
Tbc1d10b |
TBC1 domain family, member 10b |
|
increases expression |
ISO |
1 |
186,457,436 |
186,468,587 |
RGD:6480464 |
CTD |
| G |
Tbl1x |
transducin (beta)-like 1 X-linked |
|
decreases expression |
ISO |
X |
63,310,560 |
63,392,534 |
RGD:6480464 |
CTD |
| G |
Tbx21 |
T-box 21 |
|
affects response to substance |
ISO |
10 |
85,817,743 |
85,834,178 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
affects response to substance |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
decreases response to substance |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
affects response to substance |
ISO |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
affects response to substance |
ISO |
4 |
66,502,253 |
66,677,538 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
multiple interactions |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
decreases activity |
ISO |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tcirg1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
|
increases expression |
ISO |
1 |
206,420,106 |
206,429,495 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfe3 |
transcription factor binding to IGHM enhancer 3 |
|
decreases expression |
ISO |
X |
26,768,875 |
26,781,006 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 |
|
multiple interactions |
EXP |
20 |
9,492,341 |
9,510,558 |
RGD:6480464 |
CTD |
| G |
Tfg |
Trk-fused gene |
|
increases expression |
ISO |
11 |
44,826,798 |
44,853,093 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
decreases expression |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases response to substance |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgif1 |
TGFB-induced factor homeobox 1 |
|
decreases expression |
ISO |
9 |
110,043,164 |
110,052,783 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Timm17b |
translocase of inner mitochondrial membrane 17 homolog B (yeast) |
|
increases expression |
ISO |
X |
26,630,879 |
26,637,962 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases secretion |
ISO |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tlr3 |
toll-like receptor 3 |
|
affects response to substance |
ISO |
16 |
50,112,910 |
50,126,371 |
RGD:6480464 |
CTD |
| G |
Tmed9 |
transmembrane emp24 protein transport domain containing 9 |
|
increases expression |
ISO |
17 |
15,070,667 |
15,075,182 |
RGD:6480464 |
CTD |
| G |
Tmem205 |
transmembrane protein 205 |
|
increases expression |
EXP |
8 |
21,024,232 |
21,029,968 |
RGD:6480464 |
CTD |
| G |
Tmod4 |
tropomodulin 4 |
|
increases expression |
ISO |
2 |
190,029,955 |
190,034,759 |
RGD:6480464 |
CTD |
| G |
Tmsb4x |
thymosin beta 4, X-linked |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects response to substance |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
decreases response to substance |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
EXP |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
increases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases response to substance |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases response to substance |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
EXP |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnni3 |
troponin I type 3 (cardiac) |
|
increases expression |
ISO |
1 |
68,028,198 |
68,031,882 |
RGD:6480464 |
CTD |
| G |
Tns3 |
tensin 3 |
|
increases expression |
ISO |
14 |
88,999,003 |
89,182,348 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
decreases expression |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Top3b |
topoisomerase (DNA) III beta |
|
increases expression |
ISO |
11 |
86,116,936 |
86,145,314 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases acetylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53i13 |
tumor protein p53 inducible protein 13 |
|
increases expression |
ISO |
10 |
66,604,992 |
66,609,609 |
RGD:6480464 |
CTD |
| G |
Tpd52l2 |
tumor protein D52-like 2 |
|
decreases expression |
ISO |
3 |
170,631,625 |
170,650,377 |
RGD:6480464 |
CTD |
| G |
Tra2b |
transformer 2 beta homolog (Drosophila) |
|
increases expression |
ISO |
11 |
81,026,729 |
81,044,936 |
RGD:6480464 |
CTD |
| G |
Tra2b |
transformer 2 beta homolog (Drosophila) |
|
decreases expression |
EXP |
11 |
81,026,729 |
81,044,936 |
RGD:6480464 |
CTD |
| G |
Traf6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
3 |
86,827,582 |
86,847,408 |
RGD:6480464 |
CTD |
| G |
Trappc6a |
trafficking protein particle complex 6A |
|
increases expression |
ISO |
1 |
78,862,207 |
78,869,122 |
RGD:6480464 |
CTD |
| G |
Trim21 |
tripartite motif-containing 21 |
|
decreases expression |
ISO |
1 |
160,175,882 |
160,187,661 |
RGD:6480464 |
CTD |
| G |
Trit1 |
tRNA isopentenyltransferase 1 |
|
increases expression |
ISO |
5 |
142,330,963 |
142,374,390 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
increases expression |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Tsnax |
translin-associated factor X |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tspan3 |
tetraspanin 3 |
|
decreases expression |
ISO |
8 |
59,739,961 |
59,764,317 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
decreases expression |
ISO |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Tyk2 |
tyrosine kinase 2 |
|
decreases expression |
ISO |
8 |
20,096,969 |
20,149,004 |
RGD:6480464 |
CTD |
| G |
Uba2 |
ubiquitin-like modifier activating enzyme 2 |
|
increases expression |
ISO |
1 |
86,605,412 |
86,633,144 |
RGD:6480464 |
CTD |
| G |
Ube2a |
ubiquitin-conjugating enzyme E2A |
|
increases expression |
ISO |
X |
7,981,683 |
7,992,372 |
RGD:6480464 |
CTD |
| G |
Ube2b |
ubiquitin-conjugating enzyme E2B |
|
increases expression |
EXP |
10 |
37,509,322 |
37,523,900 |
RGD:6480464 |
CTD |
| G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
|
increases expression |
ISO |
14 |
45,349,287 |
45,411,823 |
RGD:6480464 |
CTD |
| G |
Ube3c |
ubiquitin protein ligase E3C |
|
affects response to substance |
ISO |
4 |
889,640 |
991,900 |
RGD:6480464 |
CTD |
| G |
Ube4a |
ubiquitination factor E4A |
|
increases expression |
ISO |
8 |
47,879,266 |
47,918,955 |
RGD:6480464 |
CTD |
| G |
Ubtd1 |
ubiquitin domain containing 1 |
|
increases expression |
ISO |
1 |
248,817,736 |
248,820,279 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases response to substance |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases response to substance |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases glucuronidation |
ISO |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
affects expression |
EXP |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil-DNA glycosylase |
|
increases expression |
ISO |
12 |
43,520,629 |
43,528,873 |
RGD:6480464 |
CTD |
| G |
Usp15 |
ubiquitin specific peptidase 15 |
|
increases expression |
ISO |
7 |
62,871,167 |
62,961,405 |
RGD:6480464 |
CTD |
| G |
UST4r |
integral membrane transport protein UST4r |
|
decreases activity |
ISO |
1 |
210,618,706 |
210,688,125 |
RGD:6480464 |
CTD |
| G |
Vamp1 |
vesicle-associated membrane protein 1 |
|
decreases expression |
ISO |
4 |
161,333,661 |
161,340,447 |
RGD:6480464 |
CTD |
| G |
Vav1 |
vav 1 guanine nucleotide exchange factor |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
EXP |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcl |
vinculin |
|
decreases expression |
ISO |
15 |
3,478,214 |
3,576,911 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
affects expression |
EXP |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance |
ISO |
7 |
136,567,614 |
136,617,280 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases expression |
ISO |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vps4a |
vacuolar protein sorting 4 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
36,887,345 |
36,900,864 |
RGD:6480464 |
CTD |
| G |
Vwa1 |
von Willebrand factor A domain containing 1 |
|
increases expression |
ISO |
5 |
172,626,372 |
172,631,591 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
decreases expression |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
decreases expression |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wbp2 |
WW domain binding protein 2 |
|
decreases expression |
ISO |
10 |
106,187,124 |
106,194,374 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
increases expression |
ISO |
7 |
60,330,517 |
60,400,697 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
increases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
decreases expression |
ISO |
10 |
63,072,128 |
63,109,833 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
increases expression |
ISO |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
multiple interactions |
ISO |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
| G |
Zfp385a |
zinc finger protein 385A |
|
increases expression |
ISO |
7 |
142,222,824 |
142,250,176 |
RGD:6480464 |
CTD |
ciprofloxacin
|
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases export |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
increases expression |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases phosphorylation |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
increases expression |
EXP |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
decreases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases expression |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
decreases activity |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases response to substance |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il3 |
interleukin 3 |
|
increases expression |
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
multiple interactions |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp13 |
matrix metallopeptidase 13 |
|
decreases expression |
ISO |
8 |
4,158,887 |
4,169,166 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
increases expression |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
decreases response to substance |
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pgd |
phosphogluconate dehydrogenase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
increases expression |
EXP |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Pon1 |
paraoxonase 1 |
|
decreases activity |
ISO |
4 |
29,936,314 |
29,964,821 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
affects localization |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top1 |
topoisomerase (DNA) I |
|
multiple interactions |
ISO |
3 |
151,428,931 |
151,512,884 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
affects binding |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
ISO |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
salicylic acid
|
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
decreases activity |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
decreases activity |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
increases expression |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
decreases activity |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Asic3 |
acid-sensing (proton-gated) ion channel 3 |
|
decreases activity |
EXP |
4 |
6,125,614 |
6,129,660 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases secretion |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
decreases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
decreases activity |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
increases uptake |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
decreases activity |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
increases uptake |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
|
increases glucuronidation |
ISO |
9 |
87,081,132 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
UST4r |
integral membrane transport protein UST4r |
|
increases uptake |
ISO |
1 |
210,618,706 |
210,688,125 |
RGD:6480464 |
CTD |
| G |
UST4r |
integral membrane transport protein UST4r |
|
decreases activity |
ISO |
1 |
210,618,706 |
210,688,125 |
RGD:6480464 |
CTD |
sulfamethazine
|
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
sulfapyridine
|
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
affects transport |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases transport |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases secretion |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases secretion |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
increases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases secretion |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
Term paths to the root
|